Literature DB >> 12909734

Molecular epidemiology of pancreatic cancer.

Donghui Li1, Li Jiao.   

Abstract

Pancreatic cancer is the fourth leading cause of cancer-related death in the United States. Currently there is no early diagnostic test and no effective treatment options for this deadly disease. Prevention of pancreatic cancer is difficult because little is known about its etiology. The main modifiable risk factors for pancreatic cancer include cigarette smoking and dietary factors. Information from molecular epidemiological study of pancreatic cancer is very limited. DNA adducts derived from exposure to polycyclic aromatic hydrocarbon, aromatic amines, and heterocyclic amines have been detected in human pancreatic tissues. DNA damages derived from oxidative stress and lipid peroxidation are also present in the pancreas. No study has demonstrated a main effect of carcinogen-metabolizing genes and DNA repair genes on the risk of pancreatic cancer thus far. However, significant effects of these genes have been observed among individuals with known carcinogen exposure, such as smoking. A number of environmental and lifestyle factors, such as smoking, alcohol, coffee consumption, and exposure to organochlorine or hydrocarbon solvent, have been associated with the frequency and spectrum of K-ras mutation in pancreatic tumors. Dietary folate intake and serum levels of folate have been associated with the risk of pancreatic cancer among male smokers. These findings demonstrate the potential of the molecular epidemiology approach in understanding the etiology of pancreatic cancer. Further efforts should be made to understand the interactive relationship between genetic and environmental factors in the etiology of pancreatic cancer, which will in turn be important in identifying the high-risk population for the primary prevention of this deadly disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12909734     DOI: 10.1385/IJGC:33:1:3

Source DB:  PubMed          Journal:  Int J Gastrointest Cancer        ISSN: 1537-3649


  97 in total

1.  Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.

Authors:  M Porta; N Malats; L Guarner; A Carrato; J Rifà; A Salas; J M Corominas; M Andreu; F X Real
Journal:  J Epidemiol Community Health       Date:  1999-11       Impact factor: 3.710

Review 2.  Metabolic genotype in relation to individual susceptibility to environmental carcinogens.

Authors:  J A Indulski; W Lutz
Journal:  Int Arch Occup Environ Health       Date:  2000-03       Impact factor: 3.015

3.  Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck.

Authors:  E M Sturgis; E J Castillo; L Li; R Zheng; S A Eicher; G L Clayman; S S Strom; M R Spitz; Q Wei
Journal:  Carcinogenesis       Date:  1999-11       Impact factor: 4.944

4.  Pathophysiologic role of oxygen free radicals in acute pancreatitis: initiating event or mediator of tissue damage?

Authors:  B Rau; B Poch; F Gansauge; A Bauer; A K Nüssler; T Nevalainen; M H Schoenberg; H G Beger
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

Review 5.  N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis.

Authors:  D W Hein
Journal:  Toxicol Lett       Date:  2000-03-15       Impact factor: 4.372

6.  Uptake of the food-derived heterocyclic amine carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and its N-hydroxy metabolite into rat pancreatic acini and hepatocytes in vitro.

Authors:  N J Butcher; R F Minchin; F F Kadlubar; K F Ilett
Journal:  Carcinogenesis       Date:  1996-04       Impact factor: 4.944

7.  Assessment of the human exposure to heterocyclic amines.

Authors:  K Augustsson; K Skog; M Jägerstad; G Steineck
Journal:  Carcinogenesis       Date:  1997-10       Impact factor: 4.944

Review 8.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

9.  Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.

Authors:  J Everhart; D Wright
Journal:  JAMA       Date:  1995 May 24-31       Impact factor: 56.272

10.  Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma.

Authors:  G Liu; P Ghadirian; D Vesprini; N Hamel; A J Paradis; G Lal; S Gallinger; S A Narod; W D Foulkes
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

View more
  16 in total

Review 1.  [Prophylactic pancreas surgery].

Authors:  P Langer; M Rothmund; D K Bartsch
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

2.  Smoking prevalance and the degree of nicotine dependence among healthcare workers at the ataturk university medical facility.

Authors:  Leyla Saglam; Ravza Bayraktar; Esra Ekbic Kadioglu; Hamit Acemoglu
Journal:  Eurasian J Med       Date:  2010-08

3.  K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients: in relation to cigarette smoking.

Authors:  Li Jiao; Jijiang Zhu; Manal M Hassan; Douglas B Evans; James L Abbruzzese; Donghui Li
Journal:  Pancreas       Date:  2007-01       Impact factor: 3.327

4.  Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studies.

Authors:  Jeanine M Genkinger; Ruifeng Li; Donna Spiegelman; Kristin E Anderson; Demetrius Albanes; Leif Bergkvist; Leslie Bernstein; Amanda Black; Piet A van den Brandt; Dallas R English; Jo L Freudenheim; Charles S Fuchs; Graham G Giles; Edward Giovannucci; R Alexandra Goldbohm; Pamela L Horn-Ross; Eric J Jacobs; Anita Koushik; Satu Männistö; James R Marshall; Anthony B Miller; Alpa V Patel; Kim Robien; Thomas E Rohan; Catherine Schairer; Rachael Stolzenberg-Solomon; Alicja Wolk; Regina G Ziegler; Stephanie A Smith-Warner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-22       Impact factor: 4.254

5.  Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer.

Authors:  Li Jiao; Melissa L Bondy; Manal M Hassan; David Z Chang; James L Abbruzzese; Douglas B Evans; Michael H Smolensky; Donghui Li
Journal:  Cancer       Date:  2007-03-01       Impact factor: 6.860

6.  Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study.

Authors:  Li Jiao; Stephanie J Weinstein; Demetrius Albanes; Philip R Taylor; Barry I Graubard; Jarmo Virtamo; Rachael Z Stolzenberg-Solomon
Journal:  Cancer Res       Date:  2011-05-03       Impact factor: 12.701

7.  Cutaneous pancreatic metastasis: a case report and review of literature.

Authors:  H Z Abdel Hafez
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

8.  The association between selected risk factors for pancreatic cancer and the expression of p53 and K-ras codon 12 mutations.

Authors:  Jon P Fryzek; David H Garabrant; Maryjean Schenk; Margaret Kinnard; Joel K Greenson; Fazlul H Sarkar
Journal:  Int J Gastrointest Cancer       Date:  2006

9.  The role of one-electron reduction of lipid hydroperoxides in causing DNA damage.

Authors:  Conor Crean; Jie Shao; Byeong Hwa Yun; Nicholas E Geacintov; Vladimir Shafirovich
Journal:  Chemistry       Date:  2009-10-12       Impact factor: 5.236

10.  Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies.

Authors:  Jeanine M Genkinger; Donna Spiegelman; Kristin E Anderson; Leif Bergkvist; Leslie Bernstein; Piet A van den Brandt; Dallas R English; Jo L Freudenheim; Charles S Fuchs; Graham G Giles; Edward Giovannucci; Susan E Hankinson; Pamela L Horn-Ross; Michael Leitzmann; Satu Männistö; James R Marshall; Marjorie L McCullough; Anthony B Miller; Douglas J Reding; Kim Robien; Thomas E Rohan; Arthur Schatzkin; Victoria L Stevens; Rachael Z Stolzenberg-Solomon; Bas A J Verhage; Alicja Wolk; Regina G Ziegler; Stephanie A Smith-Warner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-03       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.